NAPROXEN SODIUM
NDC 51013-137, Naproxen Sodium, capsule, liquid filled, from PuraCap Pharmaceutical LLC.
- Product NDC
- 51013-137
- Status
- Listed
- Labeler
- PuraCap Pharmaceutical LLC
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA208363
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51013-137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51013-137-15 | 51013013715 | 1 BOTTLE in 1 CARTON (51013-137-15) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 51013-137-28 | 51013013728 | 1 BOTTLE in 1 CARTON (51013-137-28) / 160 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 51013-137-60 | 51013013760 | 160 CAPSULE, LIQUID FILLED in 1 BOTTLE (51013-137-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51013-137 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51013-137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51013-137. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.